Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant

Nefrología - Tập 43 - Trang 1-7 - 2023
Filipa Ferreira1,2, Clara Gonçalves Bacelar3, Pedro Lisboa-Gonçalves1,2, Núria Paulo1,2, Rita Quental4, Ana Teresa Nunes1,5, Roberto Silva6, Isabel Tavares1,2,5
1Serviço de Nefrologia, Centro Hospitalar e Universitário de São João, Porto, Portugal
2Departamento de Medicina, Faculdade de Medicina, Universidade do Porto, Porto, Portugal
3Faculdade de Medicina da Universidade do Porto, Porto, Portugal
4Serviço de Genética Médica, Centro Hospitalar e Universitário de São João, Porto, Portugal
5Grupo de Investigação e Desenvolvimento em Nefrologia e Doenças Infeciosas, I3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
6Serviço de Anatomia Patológica, Centro Hospitalar e Universitário de São João, Porto, Portugal

Tài liệu tham khảo

Chinnery, 2021, Primary mitochondrial disorders overview El-Hattab, 2018, MELAS Cavero, 2015, When should a nephrologist suspect a mitochondrial disease?, Nefrologia, 35, 6 Nesbitt, 2013, The UK MRC mitochondrial disease patient cohort study: clinical phenotypes associated with the m.3243A>G mutation – implications for diagnosis and management, J Neurol Neurosurg Psychiatry, 84, 936, 10.1136/jnnp-2012-303528 Doleris, 2000, Focal segmental glomerulosclerosis associated with mitochondrial cytopathy, Kidney Int, 58, 1851, 10.1111/j.1523-1755.2000.00356.x Emma, 2017, Mitochondrial cytopathies and the kidney, Nephrol Ther, 13, S23, 10.1016/j.nephro.2017.01.014 Emma, 2016, Mitochondrial dysfunction in inherited renal disease and acute kidney injury, Nat Rev Nephrol, 12, 267, 10.1038/nrneph.2015.214 Finsterer, 2017, Renal manifestations of primary mitochondrial disorders, Biomed Rep, 6, 487, 10.3892/br.2017.892 Martín-Hernández, 2005, Renal pathology in children with mitochondrial diseases, Pediatr Nephrol, 20, 1299, 10.1007/s00467-005-1948-z Piccoli, 2012, Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndrome, BMC Nephrol, 13, 9, 10.1186/1471-2369-13-9 Sproule, 2008, Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome, Ann N Y Acad Sci, 1142, 133, 10.1196/annals.1444.011 Alcubilla-Prats, 2017, Kidney involvement in MELAS syndrome: description of 2 cases, Med Clin (Barc), 148, 357, 10.1016/j.medcli.2017.01.029 El-Hattab, 2015, MELAS syndrome: clinical manifestations, pathogenesis, and treatment options, Mol Genet Metab, 116, 4, 10.1016/j.ymgme.2015.06.004 Naing, 2014, Maternally inherited diabetes and deafness (MIDD): diagnosis and management, J Diabetes Complications, 28, 542, 10.1016/j.jdiacomp.2014.03.006 Godinho, 2017, Diabetes, deafness and renal disease, Clin Kidney J, 10, 487, 10.1093/ckj/sfx021 Narumi, 2018, Focal segmental glomerulosclerosis associated with chronic progressive external ophthalmoplegia and mitochondrial DNA A3243G mutation, Nephron, 138, 243, 10.1159/000485109 Hall, 2015, The urinary proteome and metabonome differ from normal in adults with mitochondrial disease, Kidney Int, 87, 610, 10.1038/ki.2014.297 Eirin, 2017, The emerging role of mitochondrial targeting in kidney disease, Handb Exp Pharmacol, 240, 229, 10.1007/164_2016_6 Löwik, 2005, Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis, Nephrol Dial Transplant, 20, 336, 10.1093/ndt/gfh546 Poulton, 2017, Genetic counselling for maternally inherited mitochondrial disorders, Mol Diagn Ther, 21, 419, 10.1007/s40291-017-0279-7 Parikh, 2015, Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society, Genet Med Off J Am Coll Med Genet, 17, 689 Hotta, 2001, Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation, Kidney Int, 59, 1236, 10.1046/j.1523-1755.2001.0590041236.x Santa, 2010, Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, Pharmacotherapy, 30, 1179, 10.1592/phco.30.11.1179 Yanagihara, 2001, An autopsy case of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome with chronic renal failure, Intern Med, 40, 662, 10.2169/internalmedicine.40.662 Johnson, 2019, mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases, Kidney Int, 95, 455, 10.1016/j.kint.2018.08.038 Mima, 2011, An autopsy case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with intestinal bleeding in chronic renal failure, Ren Fail, 33, 622, 10.3109/0886022X.2011.585730 de Laat, 2019, Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature, Clin Kidney J, 12, 840, 10.1093/ckj/sfz020 Doorenbos, 2001, Bicarbonate–lactate peritoneal dialysis in a patient with a mitochondriopathy, Perit Dial Int J Int Soc Perit Dial, 21, 518 Parikh, 2016, Solid organ transplantation in primary mitochondrial disease: proceed with caution, Mol Genet Metab, 118, 178, 10.1016/j.ymgme.2016.04.009 Bell, 2017, Anesthetic management of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS syndrome) in a high-risk pregnancy: a case report, A A Case Rep, 9, 38, 10.1213/XAA.0000000000000520 Santoro, 2019, Mitochondrial disease (MELAS syndrome) discovered at the start of pregnancy in a patient with advanced CKD: a clinical and ethical challenge, J Clin Med, 8, 303, 10.3390/jcm8030303 Kaufmann, 2011, Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype, Neurology, 77, 1965, 10.1212/WNL.0b013e31823a0c7f Che, 2014, Mitochondrial dysfunction in the pathophysiology of renal diseases, Am J Physiol Renal Physiol, 306, F367, 10.1152/ajprenal.00571.2013